ANALYSIS OF IMMUNE CELLS AND IMMUNOLOGICAL PROCESSES IN COVID-19
Abstract
The given scientific article analyses the dynamics of quantitative alterations in peripheral leukocytes and hematopoietic elements in blood during the period of COVID-19 and recovery. We studied the effect of SARS-CoV-2 infection on the hematopoietic system, lymphocytopenia and eosinopenia during the course of the disease, control of the recovery period from the disease by monitoring the dynamics of the number of formed elements.
Keywords
physiology, COVID-19, peripheral immune cellsHow to Cite
References
Thomas T. et al. Evidence of structural protein damage and membrane lipid remodeling in red blood cells from COVID-19 patients //Journal of proteome research. – 2020. – Т. 19. – №. 11. – С. 4455-4469.
Zini G. et al. Morphological anomalies of circulating blood cells in COVID‐19 //American journal of hematology. – 2020.
Tong X. et al. Characteristics of peripheral white blood cells in COVID-19 patients revealed by a retrospective cohort study //BMC infectious diseases. – 2021. – Т. 21. – №. 1. – С. 1-10.
Mortaz E. et al. Silent hypoxia: higher NO in red blood cells of COVID-19 patients //BMC pulmonary medicine. – 2020. – Т. 20. – №. 1. – С. 1-6.
Guan W. et al. Clinical characteristics of coronavirus disease 2019 in China //New England journal of medicine. – 2020. – Т. 382. – №. 18. – С. 1708-1720.
Wang F. et al. Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia //The Journal of infectious diseases. – 2020. – Т. 221. – №. 11. – С. 1762-1769.
Chen N. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study //The lancet. – 2020. – Т. 395. – №. 10223. – С. 507-513.
Qian G. Q. et al. Epidemiologic and clinical characteristics of 91 hospitalized patients with COVID-19 in Zhejiang, China: a retrospective, multi-centre case series //QJM: An International Journal of Medicine. – 2020. – Т. 113. – №. 7. – С. 474-481.
Liu F. et al. Patients of COVID-19 may benefit from sustained lopinavir-combined regimen and the increase of eosinophil may predict the outcome of COVID-19 progression //International Journal of Infectious Diseases. – 2020. – Т. 95. – С. 183-191.
Lippi G., Plebani M., Henry B. M. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis //Clinica chimica acta. – 2020. – Т. 506. – С. 145-148.
Jesenak M., Schwarze J. Lung Eosinophils–a Novel ‘Virus Sink’that is Defective in Asthma? //Allergy. – 2019.
Flores-Torres A. S. et al. Eosinophils and respiratory viruses //Viral immunology. – 2019. – Т. 32. – №. 5. – С. 198-207.
Zhang J. et al. Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China // Allergy. – 2020. – Т. 75. – №. 7. – С. 1730-1741.
Holter J. C. et al. Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients //Proceedings of the National Academy of Sciences. – 2020. – Т. 117. – №. 40. – С. 25018-25025.
Ахмедова Г. Б. К., Зарипов Б. Aнализ показателей биоимпеданса и основного обмена во время выздоровления от COVID-19 //Universum: химия и биология. – 2022. – №. 8-1 (98). – С. 29-32.
Зарипов Б. Физиологические особенности восстановительного периода после COVID-19 //The 13 th International scientific and practical conference “Science, innovations and education: problems and prospects” (July 28-30, 2022) CPN Publishing Group, Tokyo, Japan. 2022. 595 p. – 2022. – С. 38.
License
Copyright (c) 2024 Bakridin Zaripov, Gulsara Akhmedova, Bolta Kakhorov, Behzod Shodiev
This work is licensed under a Creative Commons Attribution 4.0 International License.